MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.110
+0.050 (4.72%)
Apr 2, 2026, 4:00 PM EDT - Market closed
MIRA Pharmaceuticals Market Cap
MIRA Pharmaceuticals has a market cap or net worth of $46.48 million as of April 2, 2026. Its market cap has increased by 133.90% in one year.
Market Cap
46.48M
Enterprise Value
36.03M
1-Year Change
133.90%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since the IPO on August 3, 2023, MIRA Pharmaceuticals's market cap has decreased from $103.22M to $46.48M, a decrease of -54.97%. That is a compound annual growth rate of -25.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 46.48M | -26.49% |
| Dec 31, 2025 | 63.23M | 234.93% |
| Dec 31, 2024 | 18.88M | 21.65% |
| Dec 29, 2023 | 15.52M | -84.96% |
| Aug 3, 2023 | 103.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pfizer | 162.35B |
| Bristol-Myers Squibb Company | 123.06B |
| Sanofi | 116.20B |
| GSK plc | 112.19B |
| Biogen | 26.54B |
| Grifols | 6.67B |
| Organon & Co. | 1.55B |
| Amarin Corporation | 304.57M |